The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Aminoglutethimide as Treatment of Postmenopausal Women with Advanced Breast Carcinoma
Abstract
Hormone-dependent breast carcinomas respond to deprivation of biologically active estrogens with objectively quantifiable tumor regression. Aminoglutethimide, a known inhibitor of steroid synthesis, is also a potent blocker of the aromatase enzyme and, thus, of estrogen production. We developed an effective regimen to inhibit estrogen production in postmenopausal women using aminoglutethimide and replacement glucocorticoid. One hundred forty-seven women initially received aminoglutethimide and replacement glucocorticoid as treatment of metastatic breast carcinoma. One hundred twenty-nine women are currently evaluable for assessment of clinical and hormonal responses. Thirty-seven percent of unselected women and 49% of estrogen receptor-positive patients experienced objective tumor regression. Responses occurred predominantly in soft tissue (47%) and bone (35%) and lasted 30 +/- 9.1 months for complete and 14 +/- 1.5 months for partial regressions. Plasma and urinary estrogen levels fell equally in responder versus nonresponder groups whereas androgen levels declined less in patients with progressive disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Santen, R. J., & Bardin, C. W. (1973) · Journal of Clinical Investigation · doi:10.1172/jci107454 · Cited by 706
Self-citationCONVERSION OF ANDROSTENEDIONE TO ESTRONE BY HUMAN FAT TISSUE
Schindler, A. E., Ebert, A., & Friedrich, E. (1972) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-35-4-627 · Cited by 319
Aromatization of Androgens by Human Abdominal and Breast Fat Tissue1
NIMROD, A., & RYAN, K. J. (1975) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-40-3-367 · Cited by 314
SANTEN, R. J., WELLS, S. A., RUNIC, S., GUPTA, C., KENDALL, J., RUDY, E. B., & SAMOJLIK, E. (1977) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-45-3-469 · Cited by 73
Self-citation
Cited by
Arimidex�: A potent and selective fourth-generation aromatase inhibitor
Plourde, P. V., Dyroff, M., & Dukes, M. (1994) · Breast Cancer Research and Treatment · doi:10.1007/bf00682745 · Cited by 258
Pros and cons of aminoglutethimide for advanced postmenopausal breast cancer
Bruning, P., Bonfrèr, J., Engelsman, E., Hamersma-v.d. Linden, E., de Jong-Bakker, M., & Nooyen, W. (1984) · Breast Cancer Research and Treatment · doi:10.1007/bf01806041 · Cited by 18
Metadata
- Authors
- SANTEN, R. J., WORGUL, T. J., LIPTON, A., HARVEY, H., BOUCHER, A., SAMOJLIK, E., & WELLS, S. A.
- Venue
- Annals of Internal Medicine
- Publisher
- American College of Physicians
- Published
- 1982-01-01
- Volume
- 96
- Issue
- 1
- Pages
- 94-101
- ISSN
- 0003-4819 (ISSN-L)
- 1539-3704
- OpenAlex
- W1991322100
- Cited by
- 172
- References
- 4
- FWCI
- 7.82
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Aminoglutethimide as Treatment of Postmenopausal Women with Advanced Breast Carcinoma. https://app.cochat.ai/papers/10.7326/0003-4819-96-1-94
- The paper
- SANTEN, R. J., WORGUL, T. J., LIPTON, A., HARVEY, H., BOUCHER, A., SAMOJLIK, E., & WELLS, S. A. (1982). Aminoglutethimide as Treatment of Postmenopausal Women with Advanced Breast Carcinoma. Annals of Internal Medicine. https://doi.org/10.7326/0003-4819-96-1-94
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.